A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers

NCT02204501 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-Drug Interaction Healthy Volunteers

Interventions

DRUG: Midazolam 5mg Syrup
DRUG: Vapendavir 264 mg BID
DRUG: Vapendavir 528 mg QD

Sponsor

Biota Scientific Management Pty Ltd